Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
- PMID: 18708387
- PMCID: PMC2561190
- DOI: 10.1158/1055-9965.EPI-08-0047
Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium
Abstract
Although active tobacco smoking has been identified as a major risk factor for head and neck cancer, involuntary smoking has not been adequately evaluated because of the relatively low statistical power in previous studies. We took advantage of data pooled in the International Head and Neck Cancer Epidemiology Consortium to evaluate the role of involuntary smoking in head and neck carcinogenesis. Involuntary smoking exposure data were pooled across six case-control studies in Central Europe, Latin America, and the United States. Adjusted odds ratios (OR) and 95% confidence interval (95% CI) were estimated for 542 cases and 2,197 controls who reported never using tobacco, and the heterogeneity among the study-specific ORs was assessed. In addition, stratified analyses were done by subsite. No effect of ever involuntary smoking exposure either at home or at work was observed for head and neck cancer overall. However, long duration of involuntary smoking exposure at home and at work was associated with an increased risk (OR for >15 years at home, 1.60; 95% CI, 1.12-2.28; P(trend) < 0.01; OR for >15 years at work, 1.55; 95% CI, 1.04-2.30; P(trend) = 0.13). The effect of duration of involuntary smoking exposure at home was stronger for pharyngeal and laryngeal cancers than for other subsites. An association between involuntary smoking exposure and the risk of head and neck cancer, particularly pharyngeal and laryngeal cancers, was observed for long duration of exposure. These results are consistent with those for active smoking and suggest that elimination of involuntary smoking exposure might reduce head and neck cancer risk among never smokers.
References
-
- Hecht SS. A biomarker of exposure to environmental tobacco smoke (ETS) and Ernst Wynder’s opinion about ETS and lung cancer. Prev Med. 2006 Oct;43(4):256–60. - PubMed
-
- Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol. 1998 Jun;11(6):559–603. - PubMed
-
- Hecht SS, Rivenson A, Braley J, et al. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 1986 Aug;46(8):4162–6. - PubMed
-
- Hecht SS, Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 1988 Jun;9(6):875–84. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50CA90388/CA/NCI NIH HHS/United States
- R01CA100264/CA/NCI NIH HHS/United States
- P01 CA068384/CA/NCI NIH HHS/United States
- R01 DA011386/DA/NIDA NIH HHS/United States
- R01 ES011740/ES/NIEHS NIH HHS/United States
- K07 CA104231/CA/NCI NIH HHS/United States
- R03CA113157/CA/NCI NIH HHS/United States
- R01ES11740/ES/NIEHS NIH HHS/United States
- R03 CA113157/CA/NCI NIH HHS/United States
- R03CA77954/CA/NCI NIH HHS/United States
- R01DA11386/DA/NIDA NIH HHS/United States
- R01 CA100264/CA/NCI NIH HHS/United States
- P50 CA090388/CA/NCI NIH HHS/United States
- P01CA068384/CA/NCI NIH HHS/United States
- R21ES011667/ES/NIEHS NIH HHS/United States
- T32 CA009142/CA/NCI NIH HHS/United States
- U01 CA096134/CA/NCI NIH HHS/United States
- U01CA96134/CA/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- R03 CA077954/CA/NCI NIH HHS/United States
- R21 ES011667/ES/NIEHS NIH HHS/United States
- K07CA104231/CA/NCI NIH HHS/United States
- T32CA09142/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
